Sandrine Marreaud, MD

European Organisation for Research and Treatment of Cancer
Brussel, Brussels Hoofdstedelijk Gewest, Belgium

Disclosure information not submitted.

Presentation(s):

• Paper 60 - STRASS2: A RANDOMIZED PHASE III STUDY OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY VERSUS SURGERY ALONE FOR PATIENTS WITH HIGH-RISK RETROPERITONEAL SARCOMA

  Saturday, November 4, 2023
  9:00 AM – 10:00 AM